Survival of node-positive (≥3) breast cancers

被引：0
|
作者：
Gulya, E [1 ]
Juhasz, M [1 ]
Kormos, Z [1 ]
Pajkos, G [1 ]
Stotz, G [1 ]
机构：
[1] Minist Interior, Cent Hosp, Dept Oncol, Budapest, Hungary
来源：
10TH INTERNATIONAL CONGRESS ON SENOLOGY - BREAST DISEASES OF THE SENOLOGIC INTERNATIONAL SOCIETY | 1998年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Survival of breast cancer patients (BCP) depends on a lot of factors. The most important prognostic factors in breast cancer are: the size of the tumour, number of lymph node metastases, nuclear grade, receptor and menopausal status, age. In addition the resistance of tumour cells for cytostatic treatment, status of immune system, accompanying diseases all affect the course of breast cancer.
引用
收藏
页码：747 / 751
页数：5
相关论文
共 50 条
  • [1] Node-related factors and survival in node-positive breast carcinomas
    Sivridis, Efthimios
    Giatroanolaki, Alexandra
    Galazios, George
    Loukourakis, Michael I.
    [J]. BREAST, 2006, 15 (03): : 382 - 389
  • [2] Telomerase activity and survival of patients with node-positive breast cancer
    Clark, GM
    Osborne, CK
    Levitt, D
    Wu, F
    Kim, NW
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (24) : 1874 - 1881
  • [3] Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells
    Ilmer, Matthias
    Mazurek, Nachman
    Gilcrease, Michael Z.
    Byrd, James C.
    Woodward, Wendy A.
    Buchholz, Thomas A.
    Acklin, Kim
    Ramirez, Karen
    Hafley, Margarete
    Alt, Eckhard
    Vykoukal, Jody
    Bresalier, Robert S.
    [J]. BREAST CANCER RESEARCH, 2016, 18
  • [4] Low expression of galectin-3 is associated with poor survival in node-positive breast cancers and mesenchymal phenotype in breast cancer stem cells
    Matthias Ilmer
    Nachman Mazurek
    Michael Z. Gilcrease
    James C. Byrd
    Wendy A. Woodward
    Thomas A. Buchholz
    Kim Acklin
    Karen Ramirez
    Margarete Hafley
    Eckhard Alt
    Jody Vykoukal
    Robert S. Bresalier
    [J]. Breast Cancer Research, 18
  • [5] Definitive axillary treatment and survival of node-positive women with breast cancer
    Kingsmore, DB
    Hole, D
    Gillis, CR
    George, WD
    [J]. BRITISH JOURNAL OF SURGERY, 1998, 85 : 67 - 67
  • [6] Survival Benefit with Radiation Therapy in Node-Positive Breast Carcinoma Patients
    Voordeckers, Mia
    Vinh-Hung, Vincent
    Lamote, Jan
    Bretz, Annette
    Storme, Guy
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (10) : 656 - 662
  • [7] Survival Benefit of Japanese Extended Lymphadenectomy for Clinically Node-Negative and Node-Positive Colorectal Cancers
    Ouchi, Akira
    Komori, Koji
    Kimura, Kenya
    Kinoshita, Takashi
    Shimizu, Yasuhiro
    Nagino, Masato
    [J]. DISEASES OF THE COLON & RECTUM, 2018, 61 (02) : 162 - 171
  • [8] Impact of Number of Positive Lymph Nodes and Lymph Node Ratio on Survival of Women with Node-Positive Breast Cancer
    Tonellotto, Fabiana
    Bergmann, Alike
    Abrahao, Karen de Souza
    de Aguiar, Suzana Sales
    Bello, Marcelo Adeodato
    Santos Thuler, Luiz Claudio
    [J]. EUROPEAN JOURNAL OF BREAST HEALTH, 2019, 15 (02) : 76 - 84
  • [9] Natural history of node-positive breast cancer: The curability of small cancers with a limited number of positive nodes
    Quiet, CA
    Ferguson, DJ
    Weichselbaum, RR
    Hellman, S
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (12) : 3105 - 3111
  • [10] Nomograms predict survival of patients with lymph node-positive, luminal a breast cancer
    Yilun Li
    Li Ma
    [J]. BMC Cancer, 21
12345